CELLULARLINE SPA (CELL.MI) Stock Fundamental Analysis
BIT:CELL - Euronext Milan - IT0005244618 - Common Stock - Currency: EUR
Taking everything into account, CELL scores 6 out of 10 in our fundamental rating. CELL was compared to 29 industry peers in the Technology Hardware, Storage & Peripherals industry. While CELL has a great health rating, its profitability is only average at the moment. A decent growth rate in combination with a cheap valuation! Better keep an eye on CELL.
1. Profitability
1.1 Basic Checks
CELL had positive earnings in the past year.
In the past year CELL had a positive cash flow from operations.
In multiple years CELL reported negative net income over the last 5 years.
CELL had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
Looking at the Return On Assets, with a value of 2.42%, CELL is in the better half of the industry, outperforming 62.07% of the companies in the same industry.
CELL has a Return On Equity of 3.98%. This is comparable to the rest of the industry: CELL outperforms 58.62% of its industry peers.
The Return On Invested Capital of CELL (5.22%) is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.42% | ||
| ROE | 3.98% | ||
| ROIC | 5.22% |
ROA(3y)-10.28%
ROA(5y)-5.5%
ROE(3y)-16.94%
ROE(5y)-9.21%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
Looking at the Profit Margin, with a value of 2.27%, CELL is in line with its industry, outperforming 51.72% of the companies in the same industry.
In the last couple of years the Profit Margin of CELL has declined.
CELL has a Operating Margin (4.17%) which is in line with its industry peers.
In the last couple of years the Operating Margin of CELL has declined.
CELL has a better Gross Margin (40.12%) than 65.52% of its industry peers.
In the last couple of years the Gross Margin of CELL has declined.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 4.17% | ||
| PM (TTM) | 2.27% | ||
| GM | 40.12% |
OM growth 3Y35.04%
OM growth 5Y-19.56%
PM growth 3YN/A
PM growth 5Y-23.32%
GM growth 3Y-2.78%
GM growth 5Y-2.73%
2. Health
2.1 Basic Checks
CELL has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
CELL has less shares outstanding than it did 1 year ago.
CELL has less shares outstanding than it did 5 years ago.
CELL has a better debt/assets ratio than last year.
2.2 Solvency
An Altman-Z score of 2.72 indicates that CELL is not a great score, but indicates only limited risk for bankruptcy at the moment.
CELL has a Altman-Z score of 2.72. This is comparable to the rest of the industry: CELL outperforms 58.62% of its industry peers.
CELL has a debt to FCF ratio of 2.15. This is a good value and a sign of high solvency as CELL would need 2.15 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 2.15, CELL is in the better half of the industry, outperforming 75.86% of the companies in the same industry.
A Debt/Equity ratio of 0.15 indicates that CELL is not too dependend on debt financing.
With an excellent Debt to Equity ratio value of 0.15, CELL belongs to the best of the industry, outperforming 82.76% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.15 | ||
| Debt/FCF | 2.15 | ||
| Altman-Z | 2.72 |
ROIC/WACC0.62
WACC8.43%
2.3 Liquidity
CELL has a Current Ratio of 2.22. This indicates that CELL is financially healthy and has no problem in meeting its short term obligations.
CELL has a better Current ratio (2.22) than 65.52% of its industry peers.
A Quick Ratio of 1.53 indicates that CELL should not have too much problems paying its short term obligations.
CELL's Quick ratio of 1.53 is fine compared to the rest of the industry. CELL outperforms 68.97% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.22 | ||
| Quick Ratio | 1.53 |
3. Growth
3.1 Past
CELL shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 16.66%, which is quite good.
CELL shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -20.43% yearly.
CELL shows a small growth in Revenue. In the last year, the Revenue has grown by 3.45%.
Measured over the past years, CELL shows a small growth in Revenue. The Revenue has been growing by 3.18% on average per year.
EPS 1Y (TTM)16.66%
EPS 3YN/A
EPS 5Y-20.43%
EPS Q2Q%-6.82%
Revenue 1Y (TTM)3.45%
Revenue growth 3Y14.1%
Revenue growth 5Y3.18%
Sales Q2Q%0.93%
3.2 Future
CELL is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 15.11% yearly.
Based on estimates for the next years, CELL will show a small growth in Revenue. The Revenue will grow by 4.54% on average per year.
EPS Next Y22.5%
EPS Next 2Y15.11%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year5.99%
Revenue Next 2Y4.54%
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 11.28 indicates a reasonable valuation of CELL.
CELL's Price/Earnings ratio is rather cheap when compared to the industry. CELL is cheaper than 82.76% of the companies in the same industry.
CELL is valuated cheaply when we compare the Price/Earnings ratio to 27.51, which is the current average of the S&P500 Index.
CELL is valuated cheaply with a Price/Forward Earnings ratio of 5.64.
CELL's Price/Forward Earnings ratio is rather cheap when compared to the industry. CELL is cheaper than 100.00% of the companies in the same industry.
CELL is valuated cheaply when we compare the Price/Forward Earnings ratio to 35.58, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 11.28 | ||
| Fwd PE | 5.64 |
4.2 Price Multiples
89.66% of the companies in the same industry are more expensive than CELL, based on the Enterprise Value to EBITDA ratio.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of CELL indicates a rather cheap valuation: CELL is cheaper than 96.55% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 3.8 | ||
| EV/EBITDA | 3.16 |
4.3 Compensation for Growth
The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as CELL's earnings are expected to grow with 15.11% in the coming years.
PEG (NY)0.5
PEG (5Y)N/A
EPS Next 2Y15.11%
EPS Next 3YN/A
5. Dividend
5.1 Amount
CELL has a Yearly Dividend Yield of 3.30%.
Compared to an average industry Dividend Yield of 2.17, CELL pays a better dividend. On top of this CELL pays more dividend than 89.66% of the companies listed in the same industry.
CELL's Dividend Yield is a higher than the S&P500 average which is at 2.35.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.3% |
5.2 History
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
33.39% of the earnings are spent on dividend by CELL. This is a low number and sustainable payout ratio.
DP33.39%
EPS Next 2Y15.11%
EPS Next 3YN/A
BIT:CELL (7/15/2025, 9:40:28 AM)
2.82
0 (0%)
Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryTechnology Hardware, Storage & Peripherals
Earnings (Last)
Earnings (Next)
Inst Owners8.42%
Inst Owner ChangeN/A
Ins Owners19.57%
Ins Owner ChangeN/A
Market Cap61.67M
Analysts82.86
Price Target4.79 (69.86%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.3% |
Yearly Dividend0.08
Dividend Growth(5Y)N/A
DP33.39%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-1.67%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 11.28 | ||
| Fwd PE | 5.64 | ||
| P/S | 0.26 | ||
| P/FCF | 3.8 | ||
| P/OCF | 2.86 | ||
| P/B | 0.45 | ||
| P/tB | 1.11 | ||
| EV/EBITDA | 3.16 |
EPS(TTM)0.25
EY8.87%
EPS(NY)0.5
Fwd EY17.72%
FCF(TTM)0.74
FCFY26.3%
OCF(TTM)0.98
OCFY34.91%
SpS11.03
BVpS6.27
TBVpS2.54
PEG (NY)0.5
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.42% | ||
| ROE | 3.98% | ||
| ROCE | 5.96% | ||
| ROIC | 5.22% | ||
| ROICexc | 5.96% | ||
| ROICexgc | 13.29% | ||
| OM | 4.17% | ||
| PM (TTM) | 2.27% | ||
| GM | 40.12% | ||
| FCFM | 6.73% |
ROA(3y)-10.28%
ROA(5y)-5.5%
ROE(3y)-16.94%
ROE(5y)-9.21%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y46.34%
ROICexcg growth 5Y-17.53%
ROICexc growth 3Y77.77%
ROICexc growth 5Y-8.95%
OM growth 3Y35.04%
OM growth 5Y-19.56%
PM growth 3YN/A
PM growth 5Y-23.32%
GM growth 3Y-2.78%
GM growth 5Y-2.73%
F-Score7
Asset Turnover1.07
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.15 | ||
| Debt/FCF | 2.15 | ||
| Debt/EBITDA | 0.89 | ||
| Cap/Depr | 38.67% | ||
| Cap/Sales | 2.2% | ||
| Interest Coverage | 3.36 | ||
| Cash Conversion | 90.51% | ||
| Profit Quality | 296.98% | ||
| Current Ratio | 2.22 | ||
| Quick Ratio | 1.53 | ||
| Altman-Z | 2.72 |
F-Score7
WACC8.43%
ROIC/WACC0.62
Cap/Depr(3y)26.8%
Cap/Depr(5y)35.01%
Cap/Sales(3y)3.22%
Cap/Sales(5y)4.78%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)16.66%
EPS 3YN/A
EPS 5Y-20.43%
EPS Q2Q%-6.82%
EPS Next Y22.5%
EPS Next 2Y15.11%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)3.45%
Revenue growth 3Y14.1%
Revenue growth 5Y3.18%
Sales Q2Q%0.93%
Revenue Next Year5.99%
Revenue Next 2Y4.54%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y44.24%
EBIT growth 3Y54.08%
EBIT growth 5Y-17%
EBIT Next Year52.68%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y98.93%
FCF growth 3Y4.84%
FCF growth 5Y6.28%
OCF growth 1Y65%
OCF growth 3Y4.12%
OCF growth 5Y1.2%